NeuroAIDS, drug abuse, and inflammation: Building collaborative research activities

Joan W. Berman, Monica J. Carson, Linda Chang, Brian M. Cox, Howard S. Fox, R. Gilberto Gonzalez, Glen R. Hanson, Kurt F. Hauser, Wen Zhe Ho, Jau Shyong Hong, Eugene O. Major, William F. Maragos, Eliezer Masliah, Justin Charles McArthur, Diane B. Miller, Avindra Nath, James P. O'Callaghan, Yuri Persidsky, Christopher Power, Thomas J. RogersWalter Royal

Research output: Contribution to journalArticle

Abstract

Neurological complications of human immunodeficiency virus (HIV) infection are a public health problem despite the availability of active antiretroviral therapies. The neuropathogenesis of HIV infection revolves around a complex cascade of events that include viral infection and glial immune activation, monocyte-macrophage brain infiltration, and secretion of a host of viral and cellular inflammatory and neurotoxic molecules. Although there is evidence that HIV-infected drug abusers experience more severe neurological disease, the biological basis for this finding is unknown. A scientific workshop organized by the National Institute on Drug Abuse (NIDA) was held on March 23-24, 2006 to address this question. The goal of the meeting was to bring together basic science and clinical researchers who are experts in NeuroAIDS, glial immunity, drugs of abuse, and/or pharmacology in order to find new approaches to understanding interactions between drug abuse and neuroAIDS. The format of the meeting was designed to stimulate open discussion and forge new multidisciplinary research collaborations. This report includes transcripts of active discussions and short presentations from invited participants. The presentations were separated into sections that included: Glial Biology, Inflammation, and HIV; Pharmacology, Neurotoxicology, and Neuroprotection; NeuroAIDS and Virology; and Virus-Drug and Immune-Drug Interactions. Research priorities were identified. Additional information about this meeting is available through links from the NIDA AIDS Research Program website ( http://www.nida.nih.gov/about/organization/arp/arp-websites.htm ).

Original languageEnglish (US)
Pages (from-to)351-399
Number of pages49
JournalJournal of NeuroImmune Pharmacology
Volume1
Issue number4
DOIs
StatePublished - Dec 2006

Fingerprint

Substance-Related Disorders
Virus Diseases
National Institute on Drug Abuse (U.S.)
HIV
Neuroglia
Inflammation
Research
Pharmacology
Virology
Macrophage Activation
Street Drugs
Drug Users
Drug Interactions
Monocytes
Immunity
Acquired Immunodeficiency Syndrome
Public Health
Research Personnel
Organizations
Viruses

Keywords

  • Brain
  • Drug abuse
  • HIV
  • Inflammation
  • NeuroAIDS
  • SIV

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)

Cite this

Berman, J. W., Carson, M. J., Chang, L., Cox, B. M., Fox, H. S., Gonzalez, R. G., ... Royal, W. (2006). NeuroAIDS, drug abuse, and inflammation: Building collaborative research activities. Journal of NeuroImmune Pharmacology, 1(4), 351-399. https://doi.org/10.1007/s11481-006-9048-9

NeuroAIDS, drug abuse, and inflammation : Building collaborative research activities. / Berman, Joan W.; Carson, Monica J.; Chang, Linda; Cox, Brian M.; Fox, Howard S.; Gonzalez, R. Gilberto; Hanson, Glen R.; Hauser, Kurt F.; Ho, Wen Zhe; Hong, Jau Shyong; Major, Eugene O.; Maragos, William F.; Masliah, Eliezer; McArthur, Justin Charles; Miller, Diane B.; Nath, Avindra; O'Callaghan, James P.; Persidsky, Yuri; Power, Christopher; Rogers, Thomas J.; Royal, Walter.

In: Journal of NeuroImmune Pharmacology, Vol. 1, No. 4, 12.2006, p. 351-399.

Research output: Contribution to journalArticle

Berman, JW, Carson, MJ, Chang, L, Cox, BM, Fox, HS, Gonzalez, RG, Hanson, GR, Hauser, KF, Ho, WZ, Hong, JS, Major, EO, Maragos, WF, Masliah, E, McArthur, JC, Miller, DB, Nath, A, O'Callaghan, JP, Persidsky, Y, Power, C, Rogers, TJ & Royal, W 2006, 'NeuroAIDS, drug abuse, and inflammation: Building collaborative research activities', Journal of NeuroImmune Pharmacology, vol. 1, no. 4, pp. 351-399. https://doi.org/10.1007/s11481-006-9048-9
Berman, Joan W. ; Carson, Monica J. ; Chang, Linda ; Cox, Brian M. ; Fox, Howard S. ; Gonzalez, R. Gilberto ; Hanson, Glen R. ; Hauser, Kurt F. ; Ho, Wen Zhe ; Hong, Jau Shyong ; Major, Eugene O. ; Maragos, William F. ; Masliah, Eliezer ; McArthur, Justin Charles ; Miller, Diane B. ; Nath, Avindra ; O'Callaghan, James P. ; Persidsky, Yuri ; Power, Christopher ; Rogers, Thomas J. ; Royal, Walter. / NeuroAIDS, drug abuse, and inflammation : Building collaborative research activities. In: Journal of NeuroImmune Pharmacology. 2006 ; Vol. 1, No. 4. pp. 351-399.
@article{7c5e1db6608242e7bd4ca27801e6c80c,
title = "NeuroAIDS, drug abuse, and inflammation: Building collaborative research activities",
abstract = "Neurological complications of human immunodeficiency virus (HIV) infection are a public health problem despite the availability of active antiretroviral therapies. The neuropathogenesis of HIV infection revolves around a complex cascade of events that include viral infection and glial immune activation, monocyte-macrophage brain infiltration, and secretion of a host of viral and cellular inflammatory and neurotoxic molecules. Although there is evidence that HIV-infected drug abusers experience more severe neurological disease, the biological basis for this finding is unknown. A scientific workshop organized by the National Institute on Drug Abuse (NIDA) was held on March 23-24, 2006 to address this question. The goal of the meeting was to bring together basic science and clinical researchers who are experts in NeuroAIDS, glial immunity, drugs of abuse, and/or pharmacology in order to find new approaches to understanding interactions between drug abuse and neuroAIDS. The format of the meeting was designed to stimulate open discussion and forge new multidisciplinary research collaborations. This report includes transcripts of active discussions and short presentations from invited participants. The presentations were separated into sections that included: Glial Biology, Inflammation, and HIV; Pharmacology, Neurotoxicology, and Neuroprotection; NeuroAIDS and Virology; and Virus-Drug and Immune-Drug Interactions. Research priorities were identified. Additional information about this meeting is available through links from the NIDA AIDS Research Program website ( http://www.nida.nih.gov/about/organization/arp/arp-websites.htm ).",
keywords = "Brain, Drug abuse, HIV, Inflammation, NeuroAIDS, SIV",
author = "Berman, {Joan W.} and Carson, {Monica J.} and Linda Chang and Cox, {Brian M.} and Fox, {Howard S.} and Gonzalez, {R. Gilberto} and Hanson, {Glen R.} and Hauser, {Kurt F.} and Ho, {Wen Zhe} and Hong, {Jau Shyong} and Major, {Eugene O.} and Maragos, {William F.} and Eliezer Masliah and McArthur, {Justin Charles} and Miller, {Diane B.} and Avindra Nath and O'Callaghan, {James P.} and Yuri Persidsky and Christopher Power and Rogers, {Thomas J.} and Walter Royal",
year = "2006",
month = "12",
doi = "10.1007/s11481-006-9048-9",
language = "English (US)",
volume = "1",
pages = "351--399",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - NeuroAIDS, drug abuse, and inflammation

T2 - Building collaborative research activities

AU - Berman, Joan W.

AU - Carson, Monica J.

AU - Chang, Linda

AU - Cox, Brian M.

AU - Fox, Howard S.

AU - Gonzalez, R. Gilberto

AU - Hanson, Glen R.

AU - Hauser, Kurt F.

AU - Ho, Wen Zhe

AU - Hong, Jau Shyong

AU - Major, Eugene O.

AU - Maragos, William F.

AU - Masliah, Eliezer

AU - McArthur, Justin Charles

AU - Miller, Diane B.

AU - Nath, Avindra

AU - O'Callaghan, James P.

AU - Persidsky, Yuri

AU - Power, Christopher

AU - Rogers, Thomas J.

AU - Royal, Walter

PY - 2006/12

Y1 - 2006/12

N2 - Neurological complications of human immunodeficiency virus (HIV) infection are a public health problem despite the availability of active antiretroviral therapies. The neuropathogenesis of HIV infection revolves around a complex cascade of events that include viral infection and glial immune activation, monocyte-macrophage brain infiltration, and secretion of a host of viral and cellular inflammatory and neurotoxic molecules. Although there is evidence that HIV-infected drug abusers experience more severe neurological disease, the biological basis for this finding is unknown. A scientific workshop organized by the National Institute on Drug Abuse (NIDA) was held on March 23-24, 2006 to address this question. The goal of the meeting was to bring together basic science and clinical researchers who are experts in NeuroAIDS, glial immunity, drugs of abuse, and/or pharmacology in order to find new approaches to understanding interactions between drug abuse and neuroAIDS. The format of the meeting was designed to stimulate open discussion and forge new multidisciplinary research collaborations. This report includes transcripts of active discussions and short presentations from invited participants. The presentations were separated into sections that included: Glial Biology, Inflammation, and HIV; Pharmacology, Neurotoxicology, and Neuroprotection; NeuroAIDS and Virology; and Virus-Drug and Immune-Drug Interactions. Research priorities were identified. Additional information about this meeting is available through links from the NIDA AIDS Research Program website ( http://www.nida.nih.gov/about/organization/arp/arp-websites.htm ).

AB - Neurological complications of human immunodeficiency virus (HIV) infection are a public health problem despite the availability of active antiretroviral therapies. The neuropathogenesis of HIV infection revolves around a complex cascade of events that include viral infection and glial immune activation, monocyte-macrophage brain infiltration, and secretion of a host of viral and cellular inflammatory and neurotoxic molecules. Although there is evidence that HIV-infected drug abusers experience more severe neurological disease, the biological basis for this finding is unknown. A scientific workshop organized by the National Institute on Drug Abuse (NIDA) was held on March 23-24, 2006 to address this question. The goal of the meeting was to bring together basic science and clinical researchers who are experts in NeuroAIDS, glial immunity, drugs of abuse, and/or pharmacology in order to find new approaches to understanding interactions between drug abuse and neuroAIDS. The format of the meeting was designed to stimulate open discussion and forge new multidisciplinary research collaborations. This report includes transcripts of active discussions and short presentations from invited participants. The presentations were separated into sections that included: Glial Biology, Inflammation, and HIV; Pharmacology, Neurotoxicology, and Neuroprotection; NeuroAIDS and Virology; and Virus-Drug and Immune-Drug Interactions. Research priorities were identified. Additional information about this meeting is available through links from the NIDA AIDS Research Program website ( http://www.nida.nih.gov/about/organization/arp/arp-websites.htm ).

KW - Brain

KW - Drug abuse

KW - HIV

KW - Inflammation

KW - NeuroAIDS

KW - SIV

UR - http://www.scopus.com/inward/record.url?scp=33751255432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751255432&partnerID=8YFLogxK

U2 - 10.1007/s11481-006-9048-9

DO - 10.1007/s11481-006-9048-9

M3 - Article

C2 - 18040811

AN - SCOPUS:33751255432

VL - 1

SP - 351

EP - 399

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 4

ER -